Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q3 2013 · 10-Q
Revenue$18.42K$18.42K+75.6% vs Q3 2012 Net Income-$780.16K-$780.16KN/M vs Q3 2012 EPS Diluted-$0.01-$0.01N/M vs Q3 2012 Gross Profit$10,037+176.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$163,733N/M Margins · derivedGross margin54.5%+19.9 pt vs Q3 2012
Operating margin-4325.0%+4059.5 pt vs Q3 2012
Net margin-4235.8%+4493.1 pt vs Q3 2012
ended Sep 30, 2013 · filed Nov 13, 2013 · 44 d after period end